<DOC>
	<DOCNO>NCT02332330</DOCNO>
	<brief_summary>This study design collect post market data use VEST , particularly saphenous vein graft right territory heart .</brief_summary>
	<brief_title>CD0104 VEST II Post Marketing Surveillance Study</brief_title>
	<detailed_description>The primary objective test early-mid term patency rate VEST support Right Coronary Artery ( RCA ) bypass graft . The research participant undergo CABG preparation CABG procedure routinely standard care . During procedure VEST implant vein graft Right Coronary Artery accord IFU . Perioperative care accord standard care . Upon discharge patient prescribe statin aspirin 6 month . Patient attend routine clinic visit 4-6 week post operatively . The last study visit occur 3-6 month post operatively . Patients undergo noninvasive coronary CT angiography .</detailed_description>
	<criteria>1 . Patient schedule onpump CABG clinical ground 2 . At least one vein graft bypass indicate right coronary artery LIMA indicate LAD clinical ground 3 . Appropriately size accessible target coronary artery , minimum diameter 1.5 mm adequate vascular bed , assess preoperative cardiac angiography . 1 . Concomitant nonCABG cardiac procedure 2 . Prior cardiac surgery 3 . Emergency CABG surgery ( cardiogenic shock , inotropic pressure support , IABP ) 4 . Contraindication onpump CABG cardioplegic arrest ( e.g . severely calcified aorta ) 5 . Calcification intend anastomotic site , assess upon open chest VEST implantation . 6 . Prior debilitate stroke less 1 year surgery 7 . Severe renal dysfunction ( Cr &gt; 2.0 mg/dL ) 8 . Concomitant lifethreatening disease likely limit life expectancy le 2 year .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>